Lantheus nabs $300K to develop capsule for colon cancer screening
Lantheus Medical Imaging has been selected to receive a $300,000 Massachusetts-Israel Innovation Partnership (MIIP) grant to develop a 3D capsule for colorectal cancer screening.
Lantheus will receive the grant upon signing a collaboration agreement with Check-Cap to develop and manufacture a 3D imaging capsule to screen for polyps and lesions associated with colorectal cancer. Check-Cap, which is based in Mount Carmel, Israel, is being awarded a grant from the Office of the Chief Scientist in Israel.
MIIP is a formal collaboration between the State of Israel and Commonwealth of Massachusetts focused on supporting innovation and entrepreneurship between Massachusetts’ and Israel’s life sciences, clean energy and technology sectors. The grant is made possible by Massachusetts Gov. Deval Patrick, Israel’s Chief Scientist Avi Hasson, the U.S.-Israel Science and Technology Foundation and the Massachusetts Technology Collaborative.
Lantheus will receive the grant upon signing a collaboration agreement with Check-Cap to develop and manufacture a 3D imaging capsule to screen for polyps and lesions associated with colorectal cancer. Check-Cap, which is based in Mount Carmel, Israel, is being awarded a grant from the Office of the Chief Scientist in Israel.
MIIP is a formal collaboration between the State of Israel and Commonwealth of Massachusetts focused on supporting innovation and entrepreneurship between Massachusetts’ and Israel’s life sciences, clean energy and technology sectors. The grant is made possible by Massachusetts Gov. Deval Patrick, Israel’s Chief Scientist Avi Hasson, the U.S.-Israel Science and Technology Foundation and the Massachusetts Technology Collaborative.